Relapsed Refractory Burkitt Lymphoma Bl clinical trials

Explore recruiting relapsed refractory burkitt lymphoma bl clinical trials.

Also recruiting in Europe

Relapsed Refractory Burkitt Lymphoma Bl trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell Malignancies (ZUMA 25) – Substudy C – Relapsed/Refractory Burkitt Lymphoma (BL)

Netherlands, France, Austria, Spain, Italy, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Relapsed Refractory Burkitt Lymphoma Bl trials by city

Relapsed Refractory Burkitt Lymphoma Bl in Toronto Relapsed Refractory Burkitt Lymphoma Bl in Vancouver Relapsed Refractory Burkitt Lymphoma Bl in Montreal Relapsed Refractory Burkitt Lymphoma Bl in Calgary Relapsed Refractory Burkitt Lymphoma Bl in Edmonton Relapsed Refractory Burkitt Lymphoma Bl in Ottawa Relapsed Refractory Burkitt Lymphoma Bl in Winnipeg Relapsed Refractory Burkitt Lymphoma Bl in Quebec City Relapsed Refractory Burkitt Lymphoma Bl in Hamilton Relapsed Refractory Burkitt Lymphoma Bl in Kitchener Relapsed Refractory Burkitt Lymphoma Bl in London Relapsed Refractory Burkitt Lymphoma Bl in Halifax Relapsed Refractory Burkitt Lymphoma Bl in New York Relapsed Refractory Burkitt Lymphoma Bl in Los Angeles Relapsed Refractory Burkitt Lymphoma Bl in Chicago Relapsed Refractory Burkitt Lymphoma Bl in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease